M. van der Feltz

447 total citations
8 papers, 86 citations indexed

About

M. van der Feltz is a scholar working on Infectious Diseases, Critical Care and Intensive Care Medicine and Oncology. According to data from OpenAlex, M. van der Feltz has authored 8 papers receiving a total of 86 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 2 papers in Critical Care and Intensive Care Medicine and 2 papers in Oncology. Recurrent topics in M. van der Feltz's work include Ultrasound in Clinical Applications (2 papers), COVID-19 Clinical Research Studies (2 papers) and HIV/AIDS drug development and treatment (2 papers). M. van der Feltz is often cited by papers focused on Ultrasound in Clinical Applications (2 papers), COVID-19 Clinical Research Studies (2 papers) and HIV/AIDS drug development and treatment (2 papers). M. van der Feltz collaborates with scholars based in Netherlands and United Kingdom. M. van der Feltz's co-authors include Rachid Massaad, Bruno H. Stricker, Karen A. Heemstra, Chris H. Bangma, Michaël P. A. Bus, J. Dieleman, Nathalie M. Delfos, Sara‐Joan Pinto‐Sietsma, M. M. E. Schneider and Penelope Ward and has published in prestigious journals such as Hypertension, Antimicrobial Agents and Chemotherapy and British journal of surgery.

In The Last Decade

M. van der Feltz

8 papers receiving 83 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. van der Feltz Netherlands 6 43 19 18 14 12 8 86
Sarah Stacey South Africa 7 60 1.4× 12 0.6× 25 1.4× 11 0.8× 27 2.3× 21 157
Luchenga Adam Mucheleng’anga Zambia 6 63 1.5× 13 0.7× 8 0.4× 4 0.3× 18 1.5× 15 129
Nina Yancheva Bulgaria 6 54 1.3× 4 0.2× 7 0.4× 18 1.3× 29 2.4× 33 86
Jolanta Popielska Poland 5 32 0.7× 6 0.3× 13 0.7× 4 0.3× 37 3.1× 13 73
Aída Gil‐Díaz Spain 5 21 0.5× 6 0.3× 19 1.1× 4 0.3× 10 0.8× 18 73
Conar O’Neil Canada 7 75 1.7× 14 0.7× 2 0.1× 10 0.7× 56 4.7× 12 173
María Leyes Spain 8 104 2.4× 22 1.2× 7 0.4× 26 1.9× 61 5.1× 15 170
Agnieszka Ołdakowska Poland 4 25 0.6× 3 0.2× 13 0.7× 5 0.4× 37 3.1× 15 68
A Scasso Italy 6 92 2.1× 4 0.2× 18 1.0× 41 2.9× 29 2.4× 11 177
Guillermo Rodríguez-Nava United States 8 71 1.7× 26 1.4× 3 0.2× 25 1.8× 70 5.8× 29 166

Countries citing papers authored by M. van der Feltz

Since Specialization
Citations

This map shows the geographic impact of M. van der Feltz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. van der Feltz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. van der Feltz more than expected).

Fields of papers citing papers by M. van der Feltz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. van der Feltz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. van der Feltz. The network helps show where M. van der Feltz may publish in the future.

Co-authorship network of co-authors of M. van der Feltz

This figure shows the co-authorship network connecting the top 25 collaborators of M. van der Feltz. A scholar is included among the top collaborators of M. van der Feltz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. van der Feltz. M. van der Feltz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Singh, Sandeep, S. J. J. Logtenberg, Paul D. van der Linden, et al.. (2021). Discontinuation of Antihypertensive Medications on the Outcome of Hospitalized Patients With Severe Acute Respiratory Syndrome-Coronavirus 2. Hypertension. 78(1). 165–173. 13 indexed citations
2.
Bus, Michaël P. A., et al.. (2020). What is the Preferred Screening Tool for COVID‐19 in Asymptomatic Patients Undergoing a Surgical or Diagnostic Procedure?. World Journal of Surgery. 44(10). 3199–3206. 18 indexed citations
3.
Delfos, Nathalie M., et al.. (2020). Measles outbreaks – potential threat for health care professionals. Infection Prevention in Practice. 2(3). 100074–100074. 2 indexed citations
4.
Bus, Michaël P. A., et al.. (2020). Screening with HRCT chest and PCR testing for COVID-19 in asymptomatic patients undergoing a surgical or diagnostic procedure. British journal of surgery. 107(10). e384–e385. 5 indexed citations
5.
Feltz, M. van der, et al.. (2009). New insights in diagnosing Schistosoma myelopathy. Journal of Infection. 60(3). 244–247. 6 indexed citations
6.
Dieleman, J., et al.. (2001). Papillary Necrosis Associated with the HIV Protease Inhibitor Indinavir. Infection. 29(4). 232–233. 17 indexed citations
7.
Feltz, M. van der. (1999). Strongyloides stercoralis infection: how to diagnose best?. The Netherlands Journal of Medicine. 55(3). 128–131. 15 indexed citations
8.
Schneider, M. M. E., et al.. (1995). Safety, tolerance, and pharmacokinetics of atevirdine mesylate (U-87201E) in asymptomatic human immunodeficiency virus-infected patients. Antimicrobial Agents and Chemotherapy. 39(3). 602–607. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Stacey Breakdown of academic impact, for papers by Luchenga Adam Mucheleng’anga Breakdown of academic impact, for papers by Nina Yancheva Breakdown of academic impact, for papers by Jolanta Popielska Breakdown of academic impact, for papers by Aída Gil‐Díaz Breakdown of academic impact, for papers by Conar O’Neil Breakdown of academic impact, for papers by María Leyes Breakdown of academic impact, for papers by Agnieszka Ołdakowska Breakdown of academic impact, for papers by A Scasso Breakdown of academic impact, for papers by Guillermo Rodríguez-Nava
Rankless by CCL
2026